Replies to post #2867 on Galectin Therapeutics Inc. (GALT)

[gss2003]

Interesting would it make sense for a BMY or
MRK to buy them with an upfront payment of say $400M and potential milestones for CX, I-O? That way they own the assets outright, have structure on future value and can accelerate trials and development of the oral therapy.